Suppr超能文献

氟哌啶醇和SCH23390诱导的多巴胺能超敏反应在大鼠中不具有叠加性。

Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.

作者信息

Parashos S A, Barone P, Marin C A, Paraschos A J, Kapitzoglou-Logothetis V, Chase T N

机构信息

National Institute of Neurological and Communicative Disorders and Stroke, Department of Health and Human Services, US Public Health Service, Bethesda, MD 20892.

出版信息

Psychopharmacology (Berl). 1989;98(2):189-92. doi: 10.1007/BF00444690.

Abstract

The effect of chronic D-1 and/or D-2 dopamine receptor blockade on apomorphine-induced behaviors was studied in rats treated for 21 days with the selective D-1 antagonist SCH23390, the predominantly D-2 antagonist haloperidol, and the combination of the two drugs at the same daily doses (0.1 and 1 mg/kg respectively). Apomorphine (0.3 mg/kg) 4 days following the last injection of the drugs increased (49-70%) stereotypic behavior in all animals as compared to saline-treated controls. Although the SCH23390-induced increase was lower than haloperidol-induced supersensitivity, stereotypies after combined administration of both drugs did not differ significantly from either, suggesting that the effects of the two drugs are not additive. Underlying receptor changes and modified D-1/D-2 receptor interactions may account for the participation of both receptor subtypes to the development of neuroleptic-induced dopaminergic supersensitivity.

摘要

在分别用选择性D-1拮抗剂SCH23390、主要的D-2拮抗剂氟哌啶醇以及以相同日剂量(分别为0.1和1mg/kg)联合使用这两种药物治疗21天的大鼠中,研究了慢性D-1和/或D-2多巴胺受体阻断对阿扑吗啡诱导行为的影响。在最后一次注射药物4天后,与生理盐水处理的对照组相比,阿扑吗啡(0.3mg/kg)使所有动物的刻板行为增加(49 - 70%)。虽然SCH23390诱导的增加低于氟哌啶醇诱导的超敏反应,但两种药物联合给药后的刻板行为与单独使用任一药物后的刻板行为相比无显著差异,这表明两种药物的作用不是相加的。潜在的受体变化和改变的D-1/D-2受体相互作用可能解释了两种受体亚型在抗精神病药物诱导的多巴胺能超敏反应发展中的参与。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验